|
1
|
Leung T, Rajendran R, Singh S, Garva R,
Krstic-Demonacos M and Demonacos C: Cytochrome P450 2E1 (CYP2E1)
regulates the response to oxidative stress and migration of breast
cancer cells. Breast Cancer Res. 15:R1072013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sheng Y, Yang H, Wu T, Zhu L, Liu L and
Liu X: Alterations of cytochrome P450s and
UDP-glucuronosyltransferases in brain under diseases and their
clinical significances. Front Pharmacol. 12:6500272021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cederbaum AI: Alcohol metabolism. Clin
Liver Dis. 16:667–685. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu D, Ma Y, Zhang W, Bao D, Dong W, Lian
H, Huang L and Zhang L: Knockdown of cytochrome P450 2E1 inhibits
oxidative stress and apoptosis in the cTnT(R141W) dilated
cardiomyopathy transgenic mice. Hypertension. 60:81–89. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Murray B, Peng H, Barbier-Torres L,
Robinson AE, Li TWH, Fan W, Tomasi ML, Gottlieb RA, Van Eyk J, Lu
Z, et al: Methionine adenosyltransferase α1 is targeted to the
mitochondrial matrix and interacts with cytochrome P450 2E1 to
lower its expression. Hepatology. 70:2018–2034. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Harjumäki R, Pridgeon CS and
Ingelman-Sundberg M: CYP2E1 in alcoholic and non-alcoholic liver
injury. Roles of ROS, reactive intermediates and lipid overload.
Int J Mol Sci. 22:82212021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tomasi ML, Ramani K, Ryoo M, Cossu C,
Floris A, Murray BJ, Iglesias-Ara A, Spissu Y and Mavila N:
SUMOylation regulates cytochrome P450 2E1 expression and activity
in alcoholic liver disease. FASEB J. 32:3278–3288. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Leung TM and Nieto N: CYP2E1 and oxidant
stress in alcoholic and non-alcoholic fatty liver disease. J
Hepatol. 58:395–398. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schattenberg JM and Czaja MJ: Regulation
of the effects of CYP2E1-induced oxidative stress by JNK signaling.
Redox Biol. 3:7–15. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Santra S, Bishnu D, Dhali GK, Santra A and
Chowdhury A: Expression of type I collagen in response to isoniazid
exposure is indirect and is facilitated by collateral induction of
cytochrome P450 2E1: An in-vitro study. PLoS One. 15:e02369922020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kuzgun G, Başaran R, Arıoğlu İnan E and
Can Eke B: Effects of insulin treatment on hepatic CYP1A1 and
CYP2E1 activities and lipid peroxidation levels in
streptozotocin-induced diabetic rats. J Diabetes Metab Disord.
19:1157–1164. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Paradies G, Paradies V, Ruggiero FM and
Petrosillo G: Oxidative stress, cardiolipin and mitochondrial
dysfunction in nonalcoholic fatty liver disease. World J
Gastroenterol. 20:14205–14218. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Navarro-Mabarak C, Camacho-Carranza R and
Espinosa-Aguirre JJ: Cytochrome P450 in the central nervous system
as a therapeutic target in neurodegenerative diseases. Drug Metab
Rev. 50:95–108. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Baltazar MT, Dinis-Oliveira RJ, de Lourdes
Bastos M, Tsatsakis AM, Duarte JA and Carvalho F: Pesticides
exposure as etiological factors of Parkinson's disease and other
neurodegenerative diseases-a mechanistic approach. Toxicol Lett.
230:85–103. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Abdelmegeed MA, Ha SK, Choi Y, Akbar M and
Song BJ: Role of CYP2E1 in mitochondrial dysfunction and hepatic
injury by alcohol and non-alcoholic substances. Curr Mol Pharmacol.
10:207–225. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yin X, Xiong W, Wang Y, Tang W, Xi W, Qian
S and Guo Y: Association of CYP2E1 gene polymorphisms with bladder
cancer risk: A systematic review and meta-analysis. Medicine
(Baltimore). 97:e119102018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Martinez-Gil N, Vidal-Gil L,
Flores-Bellver M, Maisto R, Sancho-Pelluz J, Diaz-Llopis M, M
Barcia J and Romero FJ: Ethanol-induced oxidative stress modifies
inflammation and angiogenesis biomarkers in retinal pigment
epithelial cells (ARPE-19): Role of CYP2E1 and its inhibition by
antioxidants. Antioxidants (Basel). 9:7762020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rao PS, Midde NM, Miller DD, Chauhan S,
Kumar A and Kumar S: Diallyl sulfide: Potential use in novel
therapeutic interventions in alcohol, drugs, and disease mediated
cellular toxicity by targeting cytochrome P450 2E1. Curr Drug
Metab. 16:486–503. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hong JY, Wang ZY, Smith TJ, Zhou S, Shi S,
Pan J and Yang CS: Inhibitory effects of diallyl sulfide on the
metabolism and tumorigenicity of the tobacco-specific carcinogen
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse
lung. Carcinogenesis. 13:901–904. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jin M, Ande A, Kumar A and Kumar S:
Regulation of cytochrome P450 2e1 expression by ethanol: Role of
oxidative stress-mediated pkc/jnk/sp1 pathway. Cell Death Dis.
4:e5542013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Morimoto M, Hagbjörk AL, Wan YJ, Fu PC,
Clot P, Albano E, Ingelman-Sundberg M and French SW: Modulation of
experimental alcohol-induced liver disease by cytochrome P450 2E1
inhibitors. Hepatology. 21:1610–1617. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang RH, Gao JY, Guo HT, Scott GI, Eason
AR, Wang XM and Ren J: Inhibition of CYP2E1 attenuates chronic
alcohol intake-induced myocardial contractile dysfunction and
apoptosis. Biochim Biophys Acta. 1832:128–141. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
van Riet EE, Hoes AW, Wagenaar KP, Limburg
A, Landman MA and Rutten FH: Epidemiology of heart failure: The
prevalence of heart failure and ventricular dysfunction in older
adults over time. A systematic review. Eur J Heart Fail.
18:242–252. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shakib S and Clark RA: Heart failure
pharmacotherapy and supports in the elderly-a short review. Curr
Cardiol Rev. 12:180–185. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
van der Pol A, van Gilst WH, Voors AA and
van der Meer P: Treating oxidative stress in heart failure: Past,
present and future. Eur J Heart Fail. 21:425–435. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang W, Lu D, Dong W and Zhang L, Zhang
X, Quan X, Ma C, Lian H and Zhang L: Expression of CYP2E1 increases
oxidative stress and induces apoptosis of cardiomyocytes in
transgenic mice. FEBS J. 278:1484–1492. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guan F, Yang X, Li J, Dong W, Zhang X, Liu
N, Gao S, Wang J, Zhang L and Lu D: New molecular mechanism
underlying Myc-mediated cytochrome P450 2E1 upregulation in
apoptosis and energy metabolism in the myocardium. J Am Heart
Assoc. 8:e0098712019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Westphal C, Konkel A and Schunck WH:
Cytochrome p450 enzymes in the bioactivation of polyunsaturated
Fatty acids and their role in cardiovascular disease. Adv Exp Med
Biol. 851:151–187. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thum T and Borlak J: Cytochrome P450
mono-oxygenase gene expression and protein activity in cultures of
adult cardiomyocytes of the rat. Br J Pharmacol. 130:1745–1752.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aberle NS II and Ren J: Short-term
acetaldehyde exposure depresses ventricular myocyte contraction:
Role of cytochrome P450 oxidase, xanthine oxidase, and lipid
peroxidation. Alcohol Clin Exp Res. 27:577–583. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sidorik L, Kyyamova R, Bobyk V, Kapustian
L, Rozhko O, Vigontina O, Ryabenko D, Danko I, Maksymchuk O,
Kovalenko VN, et al: Molecular chaperone, HSP60, and cytochrome
P450 2E1 co-expression in dilated cardiomyopathy. Cell Biol Int.
29:51–55. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jing L, Jin CM, Li SS, Zhang FM, Yuan L,
Li WM, Sang Y, Li S and Zhou LJ: Chronic alcohol intake-induced
oxidative stress and apoptosis: Role of CYP2E1 and calpain-1 in
alcoholic cardiomyopathy. Mol Cell Biochem. 359:283–292. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kobaladze N, Tsibadze T, Iakobashvili M
and Tabidze G: Angiotensin-converting enzyme inhibitor treatment of
heart failure due to dilated cardiomyopathy. Georgian Med News.
41–44. 2005.(In Russian). PubMed/NCBI
|
|
34
|
Cernecka H, Ochodnicka-Mackovicova K,
Kucerova D, Kmecova J, Nemcekova V, Doka G, Kyselovic J, Krenek P,
Ochodnicky P and Klimas J: Enalaprilat increases PPARβ/δ
expression, without influence on PPARα and PPARγ, and modulate
cardiac function in sub-acute model of daunorubicin-induced
cardiomyopathy. Eur J Pharmacol. 714:472–477. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Salminen WF Jr, Roberts SM, Pumford NR and
Hinson JA: Immunochemical comparison of 3′-hydroxyacetanilide and
acetaminophen binding in mouse liver. Drug Metab Dispos.
26:267–271. 1998.PubMed/NCBI
|
|
36
|
Saldaña-Ruíz S, Boadas-Vaello P,
Sedó-Cabezón L and Llorens J: Reduced systemic toxicity and
preserved vestibular toxicity following co-treatment with nitriles
and CYP2E1 inhibitors: A mouse model for hair cell loss. J Assoc
Res Otolaryngol. 14:661–671. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cederbaum AI, Wu D, Mari M and Bai J:
CYP2E1-dependent toxicity and oxidative stress in HepG2 cells. Free
Radic Biol Med. 31:1539–1543. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wollert KC, Heineke J, Westermann J, Lüdde
M, Fiedler B, Zierhut W, Laurent D, Bauer MK, Schulze-Osthoff K and
Drexler H: The cardiac Fas (APO-1/CD95) receptor/Fas ligand system:
Relation to diastolic wall stress in volume-overload hypertrophy in
vivo and activation of the transcription factor AP-1 in cardiac
myocytes. Circulation. 101:1172–1178. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yaniv G, Shilkrut M, Lotan R, Berke G,
Larisch S and Binah O: Hypoxia predisposes neonatal rat ventricular
myocytes to apoptosis induced by activation of the Fas (CD95/Apo-1)
receptor: Fas activation and apoptosis in hypoxic myocytes.
Cardiovasc Res. 54:611–623. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Thomson M and Ali M: Garlic (Allium
sativum): A review of its potential use as an anti-cancer agent.
Curr Cancer Drug Targets. 3:67–81. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nicastro HL, Ross SA and Milner JA: Garlic
and onions: Their cancer prevention properties. Cancer Prev Res
(Phila). 8:181–189. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
McCaskill ML, Rogan E and Thomas RD:
Diallyl sulfide inhibits diethylstilbestrol induced DNA damage in
human breast epithelial cells (MCF-10A). Steroids. 92:96–100. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Begriche K, Knockaert L, Massart J, Robin
MA and Fromenty B: Mitochondrial dysfunction in nonalcoholic
steatohepatitis (NASH): Are there drugs able to improve it? Drug
Discov Today Dis Mech. 6:e11–e23. 2009. View Article : Google Scholar
|
|
44
|
Louvet A and Mathurin P: Alcoholic liver
disease: Mechanisms of injury and targeted treatment. Nat Rev
Gastroenterol Hepatol. 12:231–242. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Starley BQ, Calcagno CJ and Harrison SA:
Nonalcoholic fatty liver disease and hepatocellular carcinoma: A
weighty connection. Hepatology. 51:1820–1832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wieckowska A, McCullough AJ and Feldstein
AE: Noninvasive diagnosis and monitoring of nonalcoholic
steatohepatitis: Present and future. Hepatology. 46:582–589. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Brady JF, Ishizaki H, Fukuto JM, Lin MC,
Fadel A, Gapac JM and Yang CS: Inhibition of cytochrome P-450 2E1
by diallyl sulfide and its metabolites. Chem Res Toxicol.
4:642–647. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Brady JF, Wang MH, Hong JY, Xiao F, Li Y,
Yoo JS, Ning SM, Lee MJ, Fukuto JM, Gapac JM, et al: Modulation of
rat hepatic microsomal monooxygenase enzymes and cytotoxicity by
diallyl sulfide. Toxicol Appl Pharmacol. 108:342–354. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tayal U, Prasad S and Cook SA: Genetics
and genomics of dilated cardiomyopathy and systolic heart failure.
Genome Med. 9:202017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wu D and Cederbaum AI: Cyclosporine A
protects against arachidonic acid toxicity in rat hepatocytes: Role
of CYP2E1 and mitochondria. Hepatology. 35:1420–1430. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Dai Y and Cederbaum AI: Cytotoxicity of
acetaminophen in human cytochrome P4502E1-transfected HepG2 cells.
J Pharmacol Exp Ther. 273:1497–1505. 1995.PubMed/NCBI
|
|
52
|
Isaguliants M, Smirnova O, Ivanov AV,
Kilpelainen A, Kuzmenko Y, Petkov S, Latanova A, Krotova O,
Engström G, Karpov V, et al: Oxidative stress induced by HIV-1
reverse transcriptase modulates the enzyme's performance in gene
immunization. Hum Vaccin Immunother. 9:2111–2119. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Swaminathan K, Kumar SM, Clemens DL and
Dey A: Inhibition of CYP2E1 leads to decreased advanced glycated
end product formation in high glucose treated ADH and CYP2E1
over-expressing VL-17A cells. Biochim Biophys Acta. 1830:4407–4416.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Jin L and Baillie TA: Metabolism of the
chemoprotective agent diallyl sulfide to glutathione conjugates in
rats. Chem Res Toxicol. 10:318–327. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Travessa AM and Menezes Falcão L:
Vasodilators in acute heart failure-evidence based on new studies.
Eur J Intern Med. 51:1–10. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Momma K: ACE inhibitors in pediatric
patients with heart failure. Paediatr Drugs. 8:55–69. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Smeets NJL, Schreuder MF, Dalinghaus M,
Male C, Lagler FB, Walsh J, Laer S and de Wildt SN: Pharmacology of
enalapril in children: A review. Drug Discov Today. Aug
21–2020.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
58
|
de Lannoy IA, Nespeca R and Pang KS: Renal
handling of enalapril and enalaprilat: Studies in the isolated red
blood cell-perfused rat kidney. J Pharmacol Exp Ther.
251:1211–1222. 1989.PubMed/NCBI
|
|
59
|
Tocco DJ, deLuna FA, Duncan AE, Vassil TC
and Ulm EH: The physiological disposition and metabolism of
enalapril maleate in laboratory animals. Drug Metab Dispos.
10:15–19. 1982.PubMed/NCBI
|
|
60
|
Gross DM, Sweet CS, Ulm EH, Backlund EP,
Morris AA, Weitz D, Bohn DL, Wenger HC, Vassil TC and Stone CA:
Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its
ethyl ester (MK-421) on angiotensin converting enzyme in vitro and
angiotensin I pressor responses in vivo. J Pharmacol Exp Ther.
216:552–557. 1981.PubMed/NCBI
|
|
61
|
Mailloux A, Deslandes B, Vaubourdolle M
and Baudin B: Captopril and enalaprilat decrease antioxidant
defences in human endothelial cells and are unable to protect
against apoptosis. Cell Biol Int. 27:825–830. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Hantson P: Mechanisms of toxic
cardiomyopathy. Clin Toxicol (Phila). 57:1–9. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Shang A, Cao SY, Xu XY, Gan RY, Tang GY,
Corke H, Mavumengwana V and Li HB: Bioactive compounds and
biological functions of garlic (Allium sativum L.). Foods.
8:2462019. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Abdel-Daim MM and Abdou RH: Protective
effects of diallyl sulfide and curcumin separately against
thallium-induced toxicity in rats. Cell J. 17:379–388.
2015.PubMed/NCBI
|
|
65
|
Huang CN, Horng JS and Yin MC:
Antioxidative and antiglycative effects of six organosulfur
compounds in low-density lipoprotein and plasma. J Agric Food Chem.
52:3674–3678. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Suman S and Shukla Y: Diallyl sulfide and
its role in chronic diseases prevention. Adv Exp Med Biol.
929:127–144. 2016. View Article : Google Scholar : PubMed/NCBI
|
